A detailed history of Independent Advisor Alliance transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 13,000 shares of ESPR stock, worth $27,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,000
Previous 11,500 13.04%
Holding current value
$27,690
Previous $30,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.84 - $3.24 $2,760 - $4,860
1,500 Added 13.04%
13,000 $28,000
Q1 2024

May 08, 2024

BUY
$2.02 - $3.02 $3,030 - $4,530
1,500 Added 15.0%
11,500 $30,000
Q1 2023

May 12, 2023

SELL
$1.46 - $7.3 $511 - $2,555
-350 Reduced 3.38%
10,000 $15,000
Q4 2022

Feb 13, 2023

BUY
$5.09 - $8.5 $732 - $1,224
144 Added 1.41%
10,350 $64,000
Q3 2022

Nov 04, 2022

SELL
$5.45 - $8.13 $545 - $813
-100 Reduced 0.97%
10,206 $68,000
Q2 2022

Aug 04, 2022

BUY
$4.77 - $6.67 $1,459 - $2,041
306 Added 3.06%
10,306 $66,000
Q4 2021

Feb 11, 2022

SELL
$4.81 - $11.92 $7,214 - $17,880
-1,500 Reduced 13.04%
10,000 $50,000
Q3 2021

Nov 01, 2021

BUY
$11.34 - $21.37 $130,410 - $245,755
11,500 New
11,500 $139,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $142M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.